| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.9 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |